Yulyia Lytvyn

  • Citations Per Year
Learn More
OBJECTIVE Antihyperglycemic agents, such as empagliflozin, stimulate proximal tubular natriuresis and improve cardiovascular and renal outcomes in patients with type 2 diabetes. Because dipeptidyl peptidase 4 (DPP-4) inhibitors are used in combination with sodium-glucose cotransporter 2 (SGLT2) inhibitors, we examined whether and how sitagliptin modulates(More)
In the above-mentioned article, six asterisks were added to Fig. 2. In addition, the following informationwas added to the legend: *P, 0.001, sitagliptin vs. placebo. The online version has been corrected to reflect these changes. The corrected figure is presented below. Julie A. Lovshin, Harindra Rajasekeran, Yulyia Lytvyn, Leif E. Lovblom, Shajiha Khan,(More)
  • 1